Serostim

Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for HIV-associated wasting.[1]

In December 2007, the U.S. District Court of Massachusetts - in a class-action lawsuit that involved Merck Serono and Serostim - fined Serono a total of $704 million in criminal and civil liabilities for enacting "illegal schemes to promote, market and sell its drug."[2]

References

  1. ↑ "Serostim® (somatropin) For Injection | Website For Patients". Serostim.
  2. ↑ "SERONO TO PAY $704 MILLION FOR THE ILLEGAL MARKETING OF AIDS DRUG". Department of Justice. 17 October 2005. Retrieved 23 June 2018.


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.